51
Participants
Start Date
February 28, 2013
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
Itraconazole
twice daily
Atorvastatin
single dose
Faldaprevir
once daily
Rosuvastatin
single dose
Faldaprevir
once daily
1220.61.1 Boehringer Ingelheim Investigational Site, Ingelheim
Lead Sponsor
Boehringer Ingelheim
INDUSTRY